Form 4 filed by ORBIMED ADVISORS LLC
ORBIMED ADVISORS LLC filed this Form 4 on ADARx Pharmaceuticals, Inc. with 19 transaction rows and 0 holding rows, accepted by EDGAR 2026-09-30 21:23:22 UTC.
- Accession
- 0000947871-26-000910
- Filer
- CIK 1055951
- Filed
- 2026-09-30
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
Issuer and reporting owners
Issuer: ADARx Pharmaceuticals, Inc. (CIK 1802369)
- ORBIMED ADVISORS LLC director, 10% owner
- OrbiMed Capital GP VII LLC director, 10% owner
- OrbiMed Israel GP II, L.P. director, 10% owner
- OrbiMed Advisors Israel II Ltd director, 10% owner
- OrbiMed Genesis GP LLC director, 10% owner
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-09-28 | C converted | +10,690,530 | 10,690,530 | I See footnotes | |
| Common Stock | 2026-09-28 | C converted | +2,000,962 | 12,691,492 | I See footnotes | |
| Common Stock | 2026-09-28 | C converted | +769,601 | 13,461,093 | I See footnotes | |
| Common Stock | 2026-09-28 | C converted | +564,187 | 14,025,280 | I See footnotes | |
| Common Stock | 2026-09-28 | P bought | +300,249 | $17 | 14,325,529 | I See footnotes |
| Common Stock | 2026-09-28 | C converted | +7,127,019 | 7,127,019 | I See footnotes | |
| Common Stock | 2026-09-28 | C converted | +1,333,975 | 8,460,994 | I See footnotes | |
| Common Stock | 2026-09-28 | C converted | +513,067 | 8,974,061 | I See footnotes | |
| Common Stock | 2026-09-28 | C converted | +256,448 | 9,230,509 | I See footnotes | |
| Common Stock | 2026-09-28 | P bought | +61,516 | $17 | 9,292,025 | I See footnotes |
| Common Stock | 2026-09-28 | P bought | +588,235 | $17 | 588,235 | I See footnotes |
| Series A Preferred Stock derivative | 2026-09-28 | C converted | -10,690,530 | $0 | 0 | I See footnotes |
| Series B Preferred Stock derivative | 2026-09-28 | C converted | -2,000,962 | $0 | 0 | I See footnotes |
| Series B-1 Preferred Stock derivative | 2026-09-28 | C converted | -769,601 | $0 | 0 | I See footnotes |
| Series C Preferred Stock derivative | 2026-09-28 | C converted | -564,187 | $0 | 0 | I See footnotes |
| Series A Preferred Stock derivative | 2026-09-28 | C converted | -7,127,019 | $0 | 0 | I See footnotes |
| Series B Preferred Stock derivative | 2026-09-28 | C converted | -1,333,975 | $0 | 0 | I See footnotes |
| Series B-1 Preferred Stock derivative | 2026-09-28 | C converted | -513,067 | $0 | 0 | I See footnotes |
| Series C Preferred Stock derivative | 2026-09-28 | C converted | -256,448 | $0 | 0 | I See footnotes |